ΠΠΎΠΌΠ°ΡΠ½Ρ ΡΡΠΎΡΡΠ½ΠΊΠ°540222 β’ BOM
add
Laurus Labs Ltd
ΠΠ°ΠΊΡΠΈΡΡΡ ΠΏΠΎΠΏΠ΅Ρ. Π΄Π½Ρ
612,35Β βΉ
ΠΡΠ°ΠΏΠ°Π·ΠΎΠ½ ΡΡΠ½ Π·Π° Π΄Π΅Π½Ρ
600,80Β βΉ - 615,70Β βΉ
ΠΡΠ°ΠΏΠ°Π·ΠΎΠ½ ΡΡΠ½ Π·Π° ΡΡΠΊ
386,85Β βΉ - 660,90Β βΉ
Π ΠΈΠ½ΠΊΠΎΠ²Π° ΠΊΠ°ΠΏΡΡΠ°Π»ΡΠ·Π°ΡΡΡ
327,85Β ΠΌΠ»ΡΠ΄ INR
Π‘Π΅Ρ. ΠΎΠ±ΡΡΠ³
90,70Β ΡΠΈΡ.
ΠΠΎΠ΅ΡΡΡΡΡΠ½Ρ ΡΡΠ½Π°/ΠΏΡΠΈΠ±ΡΡΠΎΠΊ
91,52
ΠΠΈΠ²ΡΠ΄Π΅Π½Π΄Π½ΠΈΠΉ ΠΏΡΠΈΠ±ΡΡΠΎΠΊ
0,20%
ΠΡΠ½ΠΎΠ²Π½Π° Π±ΡΡΠΆΠ°
NSE
Π£ Π½ΠΎΠ²ΠΈΠ½Π°Ρ
Π€ΡΠ½Π°Π½ΡΠΎΠ²Ρ Π΄Π°Π½Ρ
ΠΠ²ΡΡ ΠΏΡΠΎ ΡΡΠ½Π°Π½ΡΠΎΠ²Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΈ
ΠΠΎΡ
ΡΠ΄
Π§ΠΈΡΡΠΈΠΉ Π΄ΠΎΡ
ΡΠ΄
(INR) | Π±Π΅Ρ. 2025β―Ρ.info | ΠΠΌΡΠ½Π° Π·Π° ΡΡΠΊ |
---|---|---|
ΠΠΎΡ
ΡΠ΄ | 17,20Β ΠΌΠ»ΡΠ΄ | 19,49% |
ΠΠΏΠ΅ΡΠ°ΡΡΠΉΠ½Ρ Π²ΠΈΡΡΠ°ΡΠΈ | 6,27Β ΠΌΠ»ΡΠ΄ | 31,56% |
Π§ΠΈΡΡΠΈΠΉ Π΄ΠΎΡ
ΡΠ΄ | 2,34Β ΠΌΠ»ΡΠ΄ | 209,05% |
ΠΠ°ΡΠΆΠ° ΡΠΈΡΡΠΎΠ³ΠΎ ΠΏΡΠΈΠ±ΡΡΠΊΡ | 13,58 | 158,67% |
ΠΡΠΈΠ±ΡΡΠΎΠΊ Π½Π° Π°ΠΊΡΡΡ | 4,33 | 209,29% |
EBITDA | 4,18Β ΠΌΠ»ΡΠ΄ | 85,34% |
ΠΡΠ΅ΠΊΡΠΈΠ²Π½Π° ΡΡΠ°Π²ΠΊΠ° ΠΏΠΎΠ΄Π°ΡΠΊΡ | 25,21% | β |
ΠΡΡ
Π³Π°Π»ΡΠ΅ΡΡΡΠΊΠΈΠΉ Π±Π°Π»Π°Π½Ρ
ΠΠ°Π³Π°Π»ΡΠ½Π° Π²Π°ΡΡΡΡΡΡ Π°ΠΊΡΠΈΠ²ΡΠ²
ΠΠ°Π³Π°Π»ΡΠ½Π° ΡΡΠΌΠ° Π·ΠΎΠ±ΠΎΠ²βΡΠ·Π°Π½Ρ
(INR) | Π±Π΅Ρ. 2025β―Ρ.info | ΠΠΌΡΠ½Π° Π·Π° ΡΡΠΊ |
---|---|---|
ΠΠΎΡΡΠ²ΠΊΠΎΠ²Ρ ΠΉ ΠΊΠΎΡΠΎΡΠΊΠΎΡΡΡΠΎΠΊΠΎΠ²Ρ Π²ΠΊΠ»Π°Π΄ΠΈ | 506,40Β ΠΌΠ»Π½ | -64,25% |
ΠΠ°Π³Π°Π»ΡΠ½Π° Π²Π°ΡΡΡΡΡΡ Π°ΠΊΡΠΈΠ²ΡΠ² | 85,87Β ΠΌΠ»ΡΠ΄ | 2,38% |
ΠΠ°Π³Π°Π»ΡΠ½Π° ΡΡΠΌΠ° Π·ΠΎΠ±ΠΎΠ²βΡΠ·Π°Π½Ρ | 40,23Β ΠΌΠ»ΡΠ΄ | -5,82% |
ΠΠ°Π³. ΡΡΠΌΠ° Π²Π»Π°ΡΠ½. ΠΊΠ°ΠΏΡΡΠ°Π»Ρ | 45,64Β ΠΌΠ»ΡΠ΄ | β |
Π¦ΠΈΡΠΊΡΠ»ΡΡΡΡ Π°ΠΊΡΡΡ | 538,41Β ΠΌΠ»Π½ | β |
P/B ΠΊΠΎΠ΅ΡΡΡΡΡΠ½Ρ | 7,22 | β |
Π Π΅Π½ΡΠ°Π±Π΅Π»ΡΠ½ΡΡΡΡ Π°ΠΊΡΠΈΠ²ΡΠ² | β | β |
Π Π΅Π½ΡΠ°Π±Π΅Π»ΡΠ½ΡΡΡΡ ΠΊΠ°ΠΏΡΡΠ°Π»Ρ | 11,18% | β |
ΠΡΠΎΡΠΎΠ²ΠΈΠΉ ΠΏΠΎΡΡΠΊ
Π§ΠΈΡΡΠ° Π·ΠΌΡΠ½Π° Π·Π°Π»ΠΈΡΠΊΡ Π³ΠΎΡΡΠ²ΠΊΠΈ
(INR) | Π±Π΅Ρ. 2025β―Ρ.info | ΠΠΌΡΠ½Π° Π·Π° ΡΡΠΊ |
---|---|---|
Π§ΠΈΡΡΠΈΠΉ Π΄ΠΎΡ
ΡΠ΄ | 2,34Β ΠΌΠ»ΡΠ΄ | 209,05% |
ΠΠΎΡΡΠ²ΠΊΠ° Π²ΡΠ΄ ΠΎΠΏΠ΅ΡΠ°ΡΡΠΉ | β | β |
ΠΠΎΡΡΠ²ΠΊΠ° Π²ΡΠ΄ ΡΠ½Π²Π΅ΡΡΠΈΡΡΠΉ | β | β |
ΠΠΎΡΡΠ²ΠΊΠ° Π²ΡΠ΄ ΡΡΠ½Π°Π½ΡΡΠ²Π°Π½Π½Ρ | β | β |
Π§ΠΈΡΡΠ° Π·ΠΌΡΠ½Π° Π·Π°Π»ΠΈΡΠΊΡ Π³ΠΎΡΡΠ²ΠΊΠΈ | β | β |
ΠΡΠ»ΡΠ½ΠΈΠΉ Π³ΡΠΎΡΠΎΠ²ΠΈΠΉ ΠΏΠΎΡΡΠΊ | β | β |
ΠΠ½ΡΠΎΡΠΌΠ°ΡΡΡ
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
ΠΠ΅Π½Π΅ΡΠ°Π»ΡΠ½ΠΈΠΉ Π΄ΠΈΡΠ΅ΠΊΡΠΎΡ
ΠΠ°ΡΠ° Π·Π°ΡΠ½ΡΠ²Π°Π½Π½Ρ
2005
ΠΠ΅Π±-ΡΠ°ΠΉΡ
ΠΡΠ»ΡΠΊΡΡΡΡ ΠΏΡΠ°ΡΡΠ²Π½ΠΈΠΊΡΠ²
6Β 007